States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...
A bill moving in the West Virginia Legislature would allow the state Department of Human Services to continue drug testing welfare recipients indefinitely. The House Health Committee on Thursday ...
On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) published the final guidance for the third cycle of the Medicare Drug Price Negotiation Program, initial price applicability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results